GCI Virtual Summit Thought Leader – Professor Emmanuel Onaivi
Emmanuel participated as a thought leader at the GCI Virtual Summit 2020, joining 1000+ registered global leaders in both cannabis and psychedelics.
Check out his bio below:
Professor Emmanuel Onaivi (B. Pharm, MSc, PhD) is a Professor in the department of Biology at William Paterson University (WPU) in New Jersey, a Fulbright scholar and a Guest Scientist at the National Institute on Drug Abuse, a part of NIH in Baltimore, MD.
His research interests include the molecular biology of drug abuse and teaches Neural Basis of Behavior, Pharmacology, Bioseminar, and Anatomy and Physiology. Professor Onaivi teaches cannabis as medicine in the Pharmacology course. He has authored and co-authored many papers and edited three books on cannabis including ‘The Biology of Marijuana’, ‘Endocannabinoids: The brain and body’s marijuana and beyond’, and ‘Marijuana and cannabinoid research methods and protocols’.
Professor Emmanuel Onaivi’s pioneering research on cannabis, its constituent cannabinoids and the natural cannabis compounds produced by the human body called endocannabinoids led to:
- Cloning of CB1 cannabinoid receptors in mice
- The discovery and identification of functional neuronal CB2 cannabinoid receptors
- Postsynaptic localization of CB2 cannabinoid receptors (CB2Rs)
- Ethnic and gender differences in cannabinoid receptors
- Creation and generation of cell type specific CB2R conditional knockout mice for which Dr. Onaivi and his collaborator Dr. Liu and the University have filed for global patent
- Demonstration of the interaction between cannabinoid receptors and vanilloid receptors as a basis of why some like it hot and spicy and others do not. This research was competitively selected and presented on Capitol Hill in Washington DC to show case Undergraduate student research before the US Congress.
Professor Emmanuel Onaivi was the recipient of William Paterson University Award for Excellence in Scholarship and creative expression in 2007 and 2015. The National Institute of Health funded his research titled Behavioral effects of CB2 receptors. He has supervised Doctoral, Pre- and Postdoctoral fellows, Masters and Undergraduate student research.
He is a member of the society for Neuroscience, and Newsletter editor for the International Drug abuse Research Society and most recently selected as the Editor in Chief for Journal of Drug and Alcohol Research.
If you are a leader operating in either the cannabis or psychedelics industries, check out the GCI Virtual Summit today! You can submit an application for a complimentary ticket for our 2021 Summit here.
You can also check out exclusive interviews with some of our GCI Virtual Summit thought leaders on the Content Hub.